PKD1 gene mutation and ultrasonographic characterization in cats with renal cysts

Kotchapol Jaturanratsamee; Palin Jiwaganont; Pratch Sukumolanan; Soontaree Petchdee

doi:10.12688/f1000research.134906.1

Home Browse PKD1 gene mutation and ultrasonographic characterization in cats with...

ALL Metrics

Views

Downloads

Get PDF

Get XML

Export

▬

✚

Research Article

PKD1 gene mutation and ultrasonographic characterization in cats with renal cysts

[version 1; peer review: 1 not approved]

Kotchapol Jaturanratsamee¹, Palin Jiwaganont², Pratch Sukumolanan², Soontaree Petchdee ³

PUBLISHED 28 Jun 2023

Author details Author details

¹ Graduate School, Bio-Veterinary Science Program, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Bangkok, Thailand
² Graduate School, Veterinary Clinical Studies Program, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Bangkok, Thailand
³ Department of Large Animal and Wildlife Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Bangkok, Thailand

Kotchapol Jaturanratsamee
Roles: Data Curation, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing

Palin Jiwaganont
Roles: Data Curation, Formal Analysis, Investigation, Methodology, Writing – Review & Editing

Pratch Sukumolanan
Roles: Data Curation, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing

Soontaree Petchdee
Roles: Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Resources, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing

OPEN PEER REVIEW

REVIEWER STATUS

This article is included in the Genomics and Genetics gateway.

Abstract

Background: Polycystic kidney disease (PKD) has a complex phenotype partly explained by genetic variants related to this disease. Ultrasonography is a promising approach for defining clinical signs. This study aimed to assess kidney characteristics in cats with Polycystin-1 (PKD1) gene mutations and wild-type cats. Kidney characteristics were identified by ultrasonography.
Methods: A total of 108 cats of variable breeds aged an average of 37.01±3.50 months were included. Blood examination and biochemical tests were evaluated. For cystic formation, renal ultrasound was performed. The PKD1 gene mutation was identified via polymerase chain reaction (PCR) and DNA sequencing. Matrix correlation and effectiveness of ultrasound for PKD1 mutation detection were determined.
Results: The results showed that 19.44% of cats had PKD1 mutations, a high prevalence in Persian and Persian-related breed cats. Our results demonstrated the characteristics of kidneys in wild-type cats and cats with gene mutations. Based on ultrasonography results, there was an association between cats with gene mutations and cyst formation. The findings indicated that ultrasound did not detect cysts in cats aged 4-36 months, supporting the evidence that PKD1 gene mutations may not be present. This study found high sensitivity and renal specificity ultrasound for PKD1 heterozygous mutation. Moreover, cystic formation via renal ultrasound showed an increased risk for PKD1 mutation 2,623 times compared to normal kidneys.
Conclusions: Ultrasonographic examination, coupled with genetic investigations, may help to clarify the phenotypic variability of PKD1. The phenotypic profile of PKD1 will guide therapeutic outcomes and reduce the prevalence of PKD morbidity and mortality in cats.

Keywords

Gene, kidney disease, mutation, polycystic, ultrasonography

Corresponding author: Soontaree Petchdee

Competing interests: No competing interests were disclosed.

Grant information: The author(s) declared that no grants were involved in supporting this work.

Copyright: © 2023 Jaturanratsamee K et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite: Jaturanratsamee K, Jiwaganont P, Sukumolanan P and Petchdee S. PKD1 gene mutation and ultrasonographic characterization in cats with renal cysts [version 1; peer review: 1 not approved]. F1000Research 2023, 12:760 (https://doi.org/10.12688/f1000research.134906.1) First published: 28 Jun 2023, 12:760 (https://doi.org/10.12688/f1000research.134906.1) Latest published: 23 Feb 2024, 12:760 (https://doi.org/10.12688/f1000research.134906.3)

Introduction

The most common hereditary disease in cats is feline polycystic kidney disease (PKD). A previous study reported that the genetic condition of the PKD gene affects Persian and Persian-related cats.¹ Renal, hepatic, and pancreatic cysts are the common symptoms of feline PKD, inherited in an autosomal dominant manner.² This disease is frequently detected in the Persian breed. It is one of this breed’s most common feline genetic diseases, other than diabetes and feline lower urinary tract disease.³ This disease not only impacts the Persian breed but other breeds, including the Exotic Shorthair, British Shorthair, American Shorthair, Himalayan, Scottish fold, Ragdoll, Chartreaux, and Maine Coon breeds, may also be affected by this disease.⁴^–⁶ The feline Polycystin-1 (PKD1) gene was examined for the point of 85% of causal mutations, and the cats carried heterozygous CA transversion at c.10063 in exon 29, resulting in impaired renal function.¹^,⁷

Polycystin-1 upregulation was reported in the renal tissue from a mouse model with a PKD1 mutation. The increased expression of the mammalian target of rapamycin (mTOR) affected autophagy and apoptosis signaling in cells with a PKD1 gene mutation.¹^,⁷^–⁹ In addition, many studies have shown the mechanisms by which cyclic adenosine monophosphate (cAMP) levels influence PKD.¹⁰^–¹³ Oral administration of antioxidant agents such as DHA-enriched fish oils showed potential renoprotective effects in cats with chronic kidney disease related to PKD gene mutation.¹⁴

Ultrasonography is a useful diagnostic tool for evaluating the renal structure and renal parenchyma that cannot be evaluated through radiography.¹⁵^,¹⁶ This technique is a useful diagnostic tool for assessing and revealing renal parenchyma alteration, as that occurs when the disease progresses.¹⁷ This technique is a practical and accurate approach to diagnosing PKD. Cats with PKD have multiple hypoechoic to anechoic cysts that are round or oval in shape and clearly distinguished from the renal parenchyma.¹⁸ In a previous study, ultrasound had a sensitivity of 75% when performed at 16 weeks of age and 91% when performed at 36 weeks of age.¹⁹

This study aims to investigate the association between clinical presentations and the ultrasonography of the kidneys in wild-type cats and cats with gene mutations to provide the guide treatment and aid prevalence estimates of PKD in cats.

Methods

Animals

The Ethics Committee of Kasetsart University, Bangkok, Thailand, approved this research on September 12, 2022 (ACKU-65-VET-077). In addition, all cat owners in this study signed an informed consent agreement.³⁸ A total of 108 cats, including 18 Persian cats, 49 Persian-related breed cats, 22 domestic shorthair cats, and 19 Bengal cats, were enrolled in this study at the Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kasetsart University, from September 2022 to April 2023, as shown in Figure 1. The cat underwent a complete physical examination to evaluate the general condition. All procedures were refined as much as possible to minimize suffering to alleviate the harm to the cats in this study with a high standard that is internationally accepted (‘Best Practice Guidelines’) of veterinary clinical care for individual cats and following the ethical approvals. This study adhered to the ARRIVE guidelines.³⁹

Figure 1. Overall population in this study.

(A) Various breeds of enrolled cats. (B) Age in the different groups, including 4-12 months, 13-24 months, 25-36 months, 37-48 months, and more than 48 months. (C) Weight comprising 2.0-3.0, 3.1-4.0, 4.1-5.0, and more than 5.0 kg.

A complete blood count and serum biochemistry profile were performed for each cat. Kidney characterization was assessed by ultrasonography analysis in all cats using only gentle restraint and no sedation. The non-invasive two-dimensional (2D)-mode ultrasonography was used to define the kidney structure and size. The ultrasonography images have demonstrated that multiple cysts are a common finding in PKD1 heterozygous mutation cats, as shown in Figure 2.

Figure 2. Ultrasound image of kidneys with cysts.

(A) Normal kidney appearance without cystic formation. (B) Multiple cyst formation in renal parenchyma. In (A) and (B), the ultrasonography image was cropped for the proper size.

Polymerase chain reaction and DNA sequencing

DNA amplification with polymerase chain reaction (PCR) was performed to detect PKD1 gene mutation. PCR protocol obtained the specific forward and reversed primers from Lee et al.¹⁸ The PCR primers were PKD-forward 5′-CAGGTAGAC GGGATAGACGA-3′ and PKD-reverse 5′-TTCTTCCTGGTCAACGACTG-3′. In brief, DNA was extracted from the blood using FavorPrep Blood Genomic DNA Extraction Mini Kit (Farvogen, Taiwan). Then, 2 μl of extracted DNA from blood (Farvogen, Taiwan) was mixed with 2.5 μl of 10X Taq buffer, 0.2 μl of dNTPs (25 mM each dNTP) (Thermo Fisher Scientific, USA), 1.5 μl of MgCl₂ (25 mM), 1 μl of each custom forward and reverse primer from the manufacturer (Integrated DNA Technologies, USA) (10 μM each primer), 1 unit of Taq DNA polymerase (Thermo Fisher Scientific, USA), and 16.7 μl of nuclease-free water. The final volume of the PCR reaction was 25 μl per reaction. The PCR condition was as follows: heat-activation at 94°C for 3 minutes, 35 cycles of denaturation for 1 minute, annealing at 58°C for 1 minute, and extension at 72°C for 1 minute. Finally, the final extension was performed at 72°C for 10 minutes via Biometra Thermocycler T-Gradient ThermoBlock (Thermo Fisher Scientific, USA). The PCR product was detected with 1.5% agarose gel electrophoresis. The PCR product was visualized under gel documentation (Bio-rad, USA) at 559 bp. The PCR product was stored at -20°C until sequencing. The Barcode-tagged (BT) sequencing method was performed to detect the PCR product’s nucleotide. According to BT sequencing, the PCR product was analyzed by Celemics, Inc. (Seoul, Korea). Single nucleotide polymorphism of the PKD1 gene was detected using the BioEdit version 7.2 (RRID:SCR_007361) program and A plasmid Editor (ApE) version 2.0.60 (RRID:SCR_014266) program.

Ultrasonography

The procedure for ultrasound examination of the kidneys followed that of a previous report.⁴^,²⁰ Briefly, ultrasonography was performed using a Mindray real-time ultrasound machine (model DC-7, Shenzhen Mindray Bio-medical Electronics, Nanshan, Shenzhen, China) with a linear transducer (frequency 7.5-12.0 MHz). The kidneys were examined in the longitudinal and transverse planes. Results were recorded for each cat. The three separated regions, the renal cortex, the renal medulla, and the renal sinus, were identified. The renal sinus is the most hyperechoic component of the kidney and is surrounded by the renal pelvis and vascular branches. In the renal pelvis, ultrasonography images can be assessed using the renal crest as a landmark. The renal size can be measured by measuring from the long axis view. The renal lengths of the right and left kidneys were measured to identify the renal structure, as shown in Figure 2.

Statistical analysis

Descriptive statistics were determined as mean ± standard error of the mean (SEM). An evaluation of the effectiveness of diagnostic tests was performed. The datasets were analyzed using a paired Student’s- t-test. An odds ratio (OD) was performed to measure the association between cysts in renal parenchyma and PKD1 mutation. A correlation matrix was used to represent the correlation coefficients for different variables. Pearson’s correlation coefficient was used to determine the correlation between variables and to analyze the multiple linear regression models that contained several independent variables (GraphPad Prism (RRID: SCR_002798) Software version 9.0, USA). A P-value of 0.05 or less was indicated for statistical significance.

Results

Characteristics, ultrasonographic variables, and serum biochemical findings

The number of cats in the PKD1 mutation group was 21 (19.44 %) from an overall population of 108 cats. The cats in the PKD1 mutation group were older than those in the wild-type group (50.89 ± 9.19 vs. 33.93 ± 3.59 months, P = 0.051). However, there were no significant differences in weight between cats in the wild-type group and the PKD1 mutation group. General characteristics and ultrasonographic parameters for the cats are reported in Table 1.³⁶^,³⁷ The size of the left kidney was significantly larger in the PKD1 mutation group than in the wild-type group. Blood profiles and serum biochemistry results are reported in Table 2. The levels of other biochemical profiles, such as symmetric dimethyl arginine creatinine (SDMA), significantly differed between groups. However, the blood profile parameters of red blood cell count, hematocrit, and plasma protein were not different between the groups.

Table 1. Characteristics and ultrasonographic variables of cats.

Parameters (Mean ± SEM)	PKD1		P value
Parameters (Mean ± SEM)	Wild-type group	HET mutant group	P value
Age in months	33.93 ± 3.59	50.89 ± 9.19	P = 0.051
Weight (kg)	4.36 ± 0.46	3.34 ± 0.22	P = 0.283
Male (number [%])	72.4	61.9	-
Right kidney size (cm)	3.64 ± 0.39	4.44 ± 0.22	P = 0.082
Left kidney size (cm)	3.54 ± 0.37*	4.58 ± 0.28*	P = 0.036
Cysts number	0	12.61 ± 2.09	-

* P < 0.05.

Table 2. Serum biochemistry, red blood cell count, and hematocrit in all cats and groups.

Parameters (Mean ± SEM)	Overall population	Wild-type group	PKD1 mutant group	Reference value
BUN (mg%)	42.81 ± 3.54	38.18 ± 4.05	50.35 ± 11.39	15-34
Creatinine (mg%)	2.21 ± 0.19	1.95 ± 0.21	2.00 ± 0.33	<2.0
BUN/Creatinine ratio	19.4	19.6	25.2	7-37
Hematocrit (%)	35.87 ± 0.63	37.30 ± 3.95	33.01 ± 1.35	30-45
PP (g/dL)	7.64 ± 0.08	7.54 ± 0.80	8.0 ± 0.19	5-7.5
SDMA (ug/dL)	12.33 ± 0.74	9.36 ± 0.999.36***	20.5 ± 2.06***	<14

*** P < 0.001.

Sequencing results and ultrasonography correlation analysis of PKD1 in cats

The association between ultrasonography findings and the genotypes of PKD1 mutations was analyzed for 108 cats. PKD1 heterozygous mutations were identified in 21 cats, and the results showed significant differences between C/C and C/A genotypes for the homozygous wild-type and heterozygous mutation (Figure 3). In the present study, gene mutation cats were associated with cyst formation in cats. The ultrasonographic analysis showed renal cysts in 19 cats, and all of these cats harbored PKD1 heterozygous mutations.

Figure 3. Results of Polycystin-1 (PKD1) polymorphism from genotyping by sequencing.

(A) Gel electrophoresis represented 559 bp of target DNA of the PKD1 gene. Lane 1 represents DNA marker (M), while Lane 2 and Lane 3 show DNA products from cats with homozygous wild-type and heterozygous mutation, respectively. Lane 4 indicates negative control. (B) The barcode-tagged (BT) sequencing result of PKD1 was shown in two groups, including homozygous wildtype (C/C) and heterozygous mutation (C/A). The green arrow pointed to two peaks of cytosine and alanine, while the blue arrow represented one peak of cytosine. In (A), the gel electrophoresis image was adjusted to the darkness of the background and cropped for the proper size. In (B), the chromatogram results were cropped from BT sequencing in the Bioedit program and the arrow cursors (green and blue) were added, pointing to the mutation area for clarity and easy understanding. The text of the chromatogram nucleotide above the sequencing picture was edited in another font with bold letters.

Effectiveness of ultrasonography for detecting PKD1 gene mutation

Regarding renal ultrasonography, the effectiveness of this method was evaluated for detecting the variation of PKD1 gene polymorphism (Table 3). The sensitivity and specificity of renal ultrasound accounted for 100.00% (95% CI, 84.54 to 100.00) and 98.91% (95% CI, 94.10 to 99.94), respectively. In addition, positive predictive value (PPV) and negative predictive value (NPV) were indicated at 95.45% (95% CI, 78.20 to 99.77) and 100.00% (95% CI, 95.95 to 100.00), respectively. On top of that, according to the OD, presenting renal cysts from renal ultrasonography increased the possibility for PKD1 heterozygous mutation 2,623.00 times (95% CI, 103.2465 to 66637.8792, P < 0.0001).

Table 3. Results of the effectiveness of ultrasonography for detecting PKD1 heterozygous mutation.

Statistical test	Value	95% Confidence Interval
Sensitivity	100.00%	84.54% to 100.00%
Specificity	98.91%	94.10% to 99.94%
Positive Predictive Value (PPV)	95.45%	78.20% to 99.77%
Negative Predictive Value (NPV)	100.00%	95.95% to 100.00%
Odds ratio (OD)	2623.00	103.2465 to 66637.8792

Relationships between renal cysts and PKD1 genotypes in cats

Age, body weight, right kidney size, left kidney size, and the number of cysts were analyzed using correlation matrix analysis (Figure 4). The results showed that age and weight were negatively related to the number of cysts. However, the weight was related to kidney size. There is likely no gene mutation if the cyst is not found at less than 36 months of age. Cysts are usually found in small cats weighing between 2 and 4 kg (Figure 5).

Figure 4. Correlation between Polycystin-1 (PKD1), ultrasonography profiles, and clinical data (age and body weight).

Figure 5. Relationships between ages, weight, and Polycystin-1 (PKD1) gene.

(A) PKD1 wild-type, (B) PKD1 heterozygous mutation, (C) no renal cyst and (D) renal cysts.

Discussion

This study’s differential ultrasonographic profiles between cats with PKD1 mutations and wild-type cats may provide complementary tools for detecting and evaluating polycystic kidney disease. The findings in our study are consistent with previously reported findings that the formation of the cysts is closely related to PKD1 gene mutations with high sensitivity and specificity.¹⁸ As well as that, reports from Italy and Taiwan revealed that the sensitivity of ultrasonography was approximately 78.6 to 92.6%, and the specificity was 91 to 100%.¹⁸^,²⁰ However, a previous study reported that pure-breed Maine Coon cats developed cystic formation in renal parenchyma without PKD1 gene mutation.²¹ Therefore, the gold-standard technique of PKD1 gene mutation, PCR, and DNA sequencing is still recommended for confirming the genotype and further breeding selection consideration.

Of the total 108 cats examined by ultrasound, 19 were confirmed to have renal cysts, and in every cat with cysts found, a PKD1 mutation was present. Previous studies have indicated age-related cyst numbers for an ultrasound to diagnose PKD1 mutations. The cysts detected are sufficient for a positive diagnosis in young cats up to 12 months of age. In addition, these criteria will help to determine a positive result for PKD1 mutations if multiple bilateral cysts are detected (>10 per kidney) or if cysts are not detected in older cats. The results from this study are similar to a previous study that reported a positive correlation between the detection of renal cysts and age, as cyst detection was increased in older animals.²²

The apoptosis pathway is associated with inflammation in PKD in humans and mouse models.²³^–²⁶ Bcl-2 and Erb-b2 may be related to the pathway of PKD in cats with sarcomeric protein mutations. Inhibition of the apoptosis pathway might be associated with renal fibrosis and cyst expansion in cats with PKD.²⁷^,²⁸

Caspases are another essential target in the apoptosis mechanism.²⁹^,³⁰ Caspases are involved in preserving kidney function, suggesting caspases as a potential new target for the treatment of PKD.²⁵

PKD1 mutation is caused by disrupting the mechanism that controls the tubular diameter. The cyst characteristics were reported to be involved in cAMP signal transduction. The vasopressin that acts on the V2 receptor is the most potent catalyst for cAMP formation. Vasopressin 2 receptors are located in the collecting ducts, connecting ducts, and thickened limbs of Henle, which is the area of cyst formation. Tolvaptan has been used in treating PKD because the anti-vasopressin 2 receptor plays an important role in cyst growth.³¹^–³³ Other medications, such as metformin, which targets AMPK and cAMP signaling, have shown great promise in reducing cyst formation and cellular proliferation.³⁴^,³⁵ However, reports linking these novel therapeutic drugs with PKD in cats still require further confirmation. Future clinical trials of potential signaling pathways are crucial in PKD diagnosis and treatment in feline patients.

Conclusions

The frequency of PKD1 mutations was high in Persian and Persian-related breed cats. Such modifications were associated with the polycystic kidney phenotype. Ultrasonographic examination of cats will be a helpful tool for the routine identification of carriers of the mutated gene for polycystic kidney disease in cats. The results from this study may provide important information on clinical presentation and a gene associated with feline PKD. Genetic insights from genes may enable a more precise diagnosis of the type of renal cyst, which allows treatment or prevention strategies. Furthermore, knowing a genetic susceptibility to kidney cysts early may help to more accurately predict those most at risk of chronic kidney disease in the future.

Ethical approval

The work described in this manuscript involved using non-experimental (owned) animals. Established internationally recognized high standards (‘best practice’) of veterinary clinical care for the individual patient always followed ethical approval, and written informed consent for publication of the participants was obtained from the owners.

Data availability

Underlying data

Figshare: Raw data PKD1 in cats. https://doi.org/10.6084/m9.figshare.22957526.v1.³⁶

Extended data

Figshare: Figures. https://doi.org/10.6084/m9.figshare.22957715.v1.³⁷

Figshare: consent form. https://doi.org/10.6084/m9.figshare.22958243.v1.³⁸

Reporting guidelines

Repository: ARRIVE checklist for ‘PKD1 gene mutation and ultrasonographic characterizations in cats with renal cysts’. https://doi.org/10.6084/m9.figshare.23123414.v1.³⁹

Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).

Acknowledgments

The authors are grateful to Kasetsart University Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kasetsart University, for providing facilities for the study.

References

1. Lyons LA, Biller DS, Erdman CA, et al.: Feline polycystic kidney disease mutation identified in PKD1. J. Am. Soc. Nephrol. 2004; 15: 2548–2555. PubMed Abstract | Publisher Full Text
2. Eaton KA, Biller DS, DiBartola SP, et al.: Autosomal dominant polycystic kidney disease in Persian and Persian-cross cats. Vet. Pathol. 1997; 34: 117–126. PubMed Abstract | Publisher Full Text
3. Schirrer L, Marín-García PJ, Llobat L: Feline polycystic kidney disease: an update. Vet. Sci. 2021; 8: 269. PubMed Abstract | Publisher Full Text | Free Full Text
4. Beck C, Lavelle RB: Feline polycystic kidney disease in Persian and other cats: a prospective study using ultrasonography. Aust. Vet. J. 2001; 79: 181–184. PubMed Abstract | Publisher Full Text
5. Barrs VR, Gunew M, Foster SF, et al.: Prevalence of autosomal dominant polycystic kidney disease in Persian cats and related-breeds in Sydney and Brisbane. Aust. Vet. J. 2001; 79: 257–259. PubMed Abstract | Publisher Full Text
6. Barthez PY, Rivier P, Begon D: Prevalence of polycystic kidney disease in Persian and Persian related cats in France. J. Feline Med. Surg. 2003; 5: 345–347. PubMed Abstract | Publisher Full Text
7. Grahn R, Biller D, Young AE, et al.: Genetic testing for feline polycystic kidney disease. Anim. Genet. 2004; 35: 503–504. PubMed Abstract | Publisher Full Text
8. Nivy R, Lyons L, Aroch I, et al.: Polycystic kidney disease in four British shorthair cats with successful treatment of bacterial cyst infection. J. Small Anim. Pract. 2015; 56: 585–589. PubMed Abstract | Publisher Full Text
9. Cornec-Le Gall E, Torres VE, Harris PC: Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J. Am. Soc. Nephrol. 2018; 29: 13–23. PubMed Abstract | Publisher Full Text | Free Full Text
10. Torres VE, Chapman AB, Devuyst O, et al.: Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 2012; 367: 2407–2418. PubMed Abstract | Publisher Full Text | Free Full Text
11. Rinschen MM, Schermer B, Benzing T: Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again. J. Am. Soc. Nephrol. 2014; 25: 1140–1147. PubMed Abstract | Publisher Full Text
12. Torres VE, Chapman AB, Devuyst O, et al.: Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N. Engl. J. Med. 2017; 377: 1930–1942. PubMed Abstract | Publisher Full Text
13. Rowe I, Chiaravalli M, Mannella V, et al.: Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 2013; 19: 488–493. PubMed Abstract | Publisher Full Text | Free Full Text
14. Kobayashi S, Kawarasaki M, Aono A, et al.: Renoprotective effects of docosahexaenoic acid in cats with early chronic kidney disease due to polycystic kidney disease: a pilot study. J. Feline Med. Surg. 2022; 24: e505–e512. PubMed Abstract | Publisher Full Text
15. Domanjko-Petrič A, Černec D, Cotman M: Polycystic kidney disease: a review and occurrence in Slovenia with comparison between ultrasound and genetic testing. J. Feline Med. Surg. 2008; 10: 115–119. PubMed Abstract | Publisher Full Text
16. Wills SJ, Barrett EL, Barr FJ, et al.: Evaluation of the repeatability of ultrasound scanning for detection of feline polycystic kidney disease. J. Feline Med. Surg. 2009; 11: 993–996. PubMed Abstract | Publisher Full Text
17. Bartges JW: Chronic kidney disease in dogs and cats. Vet. Clin. Small Anim. Pract. 2012; 42: 669–692. Publisher Full Text
18. Lee YJ, Chen HY, Hsu WL, et al.: Diagnosis of feline polycystic kidney disease by combining ultrasonographic examination and PKD1 gene analysis. Vet. Rec. 2010; 167: 614–618. PubMed Abstract | Publisher Full Text
19. Biller DS, DiBartola S, Eaton KA, et al.: Inheritance of polycystic kidney disease in Persian cats. J. Hered. 1996; 87: 1–5. Publisher Full Text
20. Bonazzi M, Volta A, Gnudi G, et al.: Comparison between ultrasound and genetic testing for the early diagnosis of polycystic kidney disease in Persian and Exotic Shorthair cats. J. Feline Med. Surg. 2009; 11: 430–434. Publisher Full Text
21. Gendron K, Owczarek-Lipska M, Lang J, et al.: Maine Coon renal screening: ultrasonographical characterization and preliminary genetic analysis for common genes in cats with renal cysts. J. Feline Med. Surg. 2013; 15: 1079–1085. PubMed Abstract | Publisher Full Text
22. Noori Z, Moosavian HR, Esmaeilzadeh H, et al.: Prevalence of polycystic kidney disease in Persian and Persian related-cats referred to Small Animal Hospital, University of Tehran, Iran. Iranian J. Vet. Res. 2019; 20: 151.
23. Ecder T, Melnikov VY, Stanley M, et al.: Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int. 2002; 61: 1220–1230. PubMed Abstract | Publisher Full Text
24. Zeng F, Miyazawa T, Kloepfer LA, et al.: Deletion of ErbB4 accelerates polycystic kidney disease progression in cpk mice. Kidney Int. 2014; 86: 538–547.
25. Nowak KL, Edelstein CL: Apoptosis and autophagy in polycystic kidney disease (PKD). Cell. Signal. 2020; 68: 109518. Publisher Full Text
26. Richards T, Modarage K, Malik SA, et al.: The cellular pathways and potential therapeutics of Polycystic Kidney Disease. Biochem. Soc. Trans. 2021; 49: 1171–1188. Publisher Full Text
27. Bilgen N, Bişkin Türkmen MB, Çınar Kul B, et al.: Prevalence of PKD1 gene mutation in cats in Turkey and pathogenesis of feline polycystic kidney disease. J. Vet. Diagn. Investig. 2020; 32: 549–555. PubMed Abstract | Publisher Full Text | Free Full Text
28. Xue C, Mei C-L: Polycystic kidney disease and renal fibrosis. Renal fibrosis: mechanisms and therapies.2019; pp. 81–100.
29. Swenson-Fields KI, Ward CJ, Lopez ME, et al.: Caspase-1 and the inflammasome promote polycystic kidney disease progression. Front. Mol. Biosci. 2022; 9: 1300. Publisher Full Text
30. Tao Y, Kim J, Faubel S, et al.: Caspase inhibition reduces tubular apoptosis and proliferation, slowing disease progression in polycystic kidney disease. Proc. Natl. Acad. Sci. 2005; 102: 6954–6959.
31. Patel V, Chowdhury R, Igarashi P: Advances in the pathogenesis and treatment of polycystic kidney disease. Curr. Opin. Nephrol. Hypertens. 2009; 18: 99–106. PubMed Abstract | Publisher Full Text | Free Full Text
32. Blair HA: Tolvaptan: a review in autosomal dominant polycystic kidney disease. Drugs. 2019; 79: 303–313. Publisher Full Text
33. Bellos I: Safety profile of Tolvaptan in the treatment of autosomal dominant polycystic kidney disease. Ther. Clin. Risk Manag. 2021; 649–656.
34. Lian X, Wu X, Li Z, et al.: The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease. Br. J. Pharmacol. 2019; 176: 711–724. PubMed Abstract | Publisher Full Text | Free Full Text
35. Gattone VH, Wang X, Harris PC, et al.: Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 2003; 9: 1323–1326. PubMed Abstract | Publisher Full Text
36. Petchdee S: Raw data PKD1 in cats. [Dataset]. figshare. 2023. Publisher Full Text
37. Petchdee S: Figures. [Dataset]. figshare. 2023. Publisher Full Text
38. Petchdee S: consent form. [Dataset]. figshare. 2023. Publisher Full Text
39. Petchdee S: ARRIVE checklist_edited. [Dataset]. figshare. 2023. Publisher Full Text

Comments on this article Comments (0)

Version 3

VERSION 3 PUBLISHED 28 Jun 2023

Author details Author details

Kotchapol Jaturanratsamee
Roles: Data Curation, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing

Palin Jiwaganont
Roles: Data Curation, Formal Analysis, Investigation, Methodology, Writing – Review & Editing

Pratch Sukumolanan
Roles: Data Curation, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing

Competing interests

No competing interests were disclosed.

Grant information

The author(s) declared that no grants were involved in supporting this work.

Article Versions (3)

version 3

Revised

Published: 23 Feb 2024, 12:760

https://doi.org/10.12688/f1000research.134906.3

version 2

Revised

Published: 27 Oct 2023, 12:760

https://doi.org/10.12688/f1000research.134906.2

version 1

Published: 28 Jun 2023, 12:760

https://doi.org/10.12688/f1000research.134906.1

© 2023 Jaturanratsamee K et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download

Export To

metrics

	Views	Downloads
F1000Research	-	-
PubMed Central Data from PMC are received and updated monthly.	-	-

Citations

SEE MORE DETAILS

CITE

how to cite this article

Jaturanratsamee K, Jiwaganont P, Sukumolanan P and Petchdee S. PKD1 gene mutation and ultrasonographic characterization in cats with renal cysts [version 1; peer review: 1 not approved]. F1000Research 2023, 12:760 (https://doi.org/10.12688/f1000research.134906.1)

NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.

track

receive updates on this article

Track an article to receive email alerts on any updates to this article.

Open Peer Review

Version 1

VERSION 1

PUBLISHED 28 Jun 2023

Views

Reviewer Report 16 Oct 2023

Leslie A. Lyons, Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO, USA

Not Approved

https://doi.org/10.5256/f1000research.147998.r183547

The manuscript by Jaturanratsamee et al., entitled “PKD1 gene mutation and ultrasonographic characterization in cats with renal cysts” describes the evaluation of 108 cats of variable breeds. Blood examination and biochemical tests were evaluated. For cyst detection, renal ultrasound was performed. The PKD1 gene mutation was identified via polymerase chain reaction (PCR) and DNA sequencing. 19.44% (21 of 108) of cats had PKD1 mutations, a high prevalence in Persian and Persian-related breed cats.

The authors present a dataset including 108 cats in which 21 had the variant for PKD1. The dataset is important however the authors need to do some different presentations that would be of more significant value to the veterinary and PKD research communities. Hence. “partly” for the interpretation of data. Partly for data presentation as all US images are not available.

The authors should note 87 cats had no cysts at all. What is the frequency of singular cysts in humans, I think this supports cats rarely have singular cysts, or at least less commonly than humans.

18 Persian cats, 49 Persian-related breed cats, 22 domestic shorthair cats, and 19 Bengal cats – need table with age at US for each cat – the figures are less useful. Produce a summary table that summarizes groups, per breed, the cats without the PKD1 variant and then provides each breed cat that had PKD individually. Which cat had PKD1 variant but no cysts – what was the cat’s age? Mention this in the text.

Scottish Folds are popular in eastern countries, however, the rate of PKD is high – contrast to other, recent population data suggesting PKD1 is a very low rate in Persians and other breeds.

BUN high for both populations – age correlation is important – please comment.

PKD is one of the most common hereditary disease – actually simple Mendelian diseases in cats. HCM may be more common but has a complex inheritance.

Was the hair clipped for the US evaluations or alcohol or gel applied for US?

Overall creatinine for overall population was 2.21 _ 0.19 – odd not intermediate – correct?

Which was most predictive of PKD – renal failure, number of cysts, age, BUN, SDMA? Any cats in renal failure?

Was left to right kidney size significantly different in PKD1 cats?

Figure 4 would be better with biochemistries and cysts, kidney size, in affected cats versus normal. More figures like this, less pie charts.

The results showed that age and weight were negatively related to the number of cysts? I think this is misstated in results.

"The feline Polycystin-1 (PKD1) gene was examined for the point of 85% of causal mutations" – not sure what this means.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Partly
Are the conclusions drawn adequately supported by the results?

Partly

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Genetics PKD feline diseases

I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.

CITE

Report a concern

Author Response 30 Nov 2023

Soontaree Petchdee, Department of Large Animal and Wildlife Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand

30 Nov 2023

Author Response

Reviewer1:
The authors present a dataset including 108 cats in which 21 had the variant for PKD1. The dataset is important however the authors need to do some different presentations ... Continue reading Reviewer1:
The authors present a dataset including 108 cats in which 21 had the variant for PKD1. The dataset is important however the authors need to do some different presentations that would be of more significant value to the veterinary and PKD research communities. Hence. “partly” for the interpretation of data. Partly for data presentation as all US images are not available.
The authors should note 87 cats had no cysts at all. What is the frequency of singular cysts in humans, I think this supports cats rarely have singular cysts, or at least less commonly than humans.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion section.
Of the total 108 cats examined by ultrasound, no cyst was found in 87 cats of the wild-type group. However,19 cats were confirmed to have renal cysts, and in every cat with cysts found, a PKD1 mutation was presented.

18 Persian cats, 49 Persian-related breed cats, 22 domestic shorthair cats, and 19 Bengal cats – need a table with age at US for each cat – the figures are less useful. Produce a summary table that summarizes groups, per breed, the cats without the PKD1 variant and then provide each breed cat that had PKD individually.
Which cat had PKD1 variant but no cysts – what was the cat’s age? Mention this in the text.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in Table 3 and mentioned more information in the results part. We apologize for this point.
However, there was a 51-month-old domestic shorthair cat without the PKD1 gene mutation developing the cysts in renal parenchyma. Table 3 demonstrates the number of cats in various breeds with PKD1 gene mutation and renal cyst development.

Scottish Folds are popular in eastern countries, however, the rate of PKD is high – contrast to other, recent population data suggesting PKD1 is a very low rate in Persians and other breeds.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in the discussion section.
This study found that the rate of PKD1 gene mutation was high in Persian and Persian-related breed cats including Scottish Folds cats, Previous reports has been suggested that PKD1 mutation was found at very low rates in Persians and other breeds which is contrary to our results. The high number of PKD1 mutations that had been reported may be due to the Persian and Persian-related breed cats being a popular cat breed in eastern countries and Thailand.

BUN is high for both populations – age correlation is important – please comment.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results and discussion part.
As indicated in Table 2, the levels of BUN were mildly elevated than the normal reference value. However, Pearson’s correlation results revealed that there was no correlation between age and BUN levels in WT (r=0.1436 P = 0.62) and PKD1 mutation group (r=0.3234 P = 0.099).

PKD is one of the most common hereditary diseases – actually simple Mendelian diseases in cats. HCM may be more common but has a complex inheritance.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
Feline polycystic kidney disease (PKD) is an inherited disorder that develops cysts in the renal parenchyma.

Was the hair clipped for the US evaluations or alcohol or gel applied for US?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the materials and methods part.
In our ultrasonographic examination, all cats were clipped the hair in the abdominal area and the ultrasonographic gel was used in all cats.

Overall creatinine for overall population was 2.21 _ 0.19 – odd not intermediate – correct?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
Additionally, the results of average creatinine levels in overall cats were elevated. Nonetheless, our results demonstrated that increasing creatinine exceeding 2.0 mg% may slightly increase the possibility for renal cyst formation by 1.41 times (95% CI, 0.3827 to 5.1764, P = 0.6070).

Which was most predictive of PKD – renal failure, number of cysts, age, BUN, SDMA? Any cats in renal failure?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part. The enrolled cats in this study are represented with either renal failure or non-renal failure.
Therefore, cats with increasing SDMA, an age exceeding 36 months, body weight between 2-4 kg, and renal cyst formation from ultrasonographic examination are a high possibility of PKD1 gene mutation with PKD disorder.
According to the elevated BUN in our study, the enrolled cats in this study are represented with either renal failure or non-renal failure. The high levels of BUN and increasing age were not related in contrast with the prior study from humans at that age and BUN indicated a positive correlation.

Was left to right kidney size significantly different in PKD1 cats?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
However, there was no statistically significant difference between right and left kidney size in cats affected with PKD1 mutation (P=0.9980).

Figure 4 would be better with biochemistries and cysts, kidney size, in affected cats versus normal. More figures like this, less pie charts.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript and added Figure 4.

The results showed that age and weight were negatively related to the number of cysts? I think this is misstated in results.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion part. As in Figure 4, the results of matrix correlation show a negative correlation between the number of cysts and body weight (r=0.08) and age (r=0.44).
Nevertheless, our study indicated a negative correlation between the age and the number of cysts in recruited cats. Moreover, the cats in this study have a negative correlation between cyst number and body weight. This could potentially result from the manifestation of PKD symptoms in cats with PKD1 mutation.

"The feline Polycystin-1 (PKD1) gene was examined for the point of 85% of causal mutations" – not sure what this means.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
The polycystin-1 (PKD1) gene mutation was indicated for 85% of human autosomal dominant polycystic kidney disease (ADPKD). The mutation of the PKD1 gene in cats carried heterozygous CA transversion at c.10063 in exon 29, resulting in impaired renal function.

Best regards
Soontaree Petchdee
Corresponding author
Reviewer1:
The authors present a dataset including 108 cats in which 21 had the variant for PKD1. The dataset is important however the authors need to do some different presentations that would be of more significant value to the veterinary and PKD research communities. Hence. “partly” for the interpretation of data. Partly for data presentation as all US images are not available.
The authors should note 87 cats had no cysts at all. What is the frequency of singular cysts in humans, I think this supports cats rarely have singular cysts, or at least less commonly than humans.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion section.
Of the total 108 cats examined by ultrasound, no cyst was found in 87 cats of the wild-type group. However,19 cats were confirmed to have renal cysts, and in every cat with cysts found, a PKD1 mutation was presented.

18 Persian cats, 49 Persian-related breed cats, 22 domestic shorthair cats, and 19 Bengal cats – need a table with age at US for each cat – the figures are less useful. Produce a summary table that summarizes groups, per breed, the cats without the PKD1 variant and then provide each breed cat that had PKD individually.
Which cat had PKD1 variant but no cysts – what was the cat’s age? Mention this in the text.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in Table 3 and mentioned more information in the results part. We apologize for this point.
However, there was a 51-month-old domestic shorthair cat without the PKD1 gene mutation developing the cysts in renal parenchyma. Table 3 demonstrates the number of cats in various breeds with PKD1 gene mutation and renal cyst development.

Scottish Folds are popular in eastern countries, however, the rate of PKD is high – contrast to other, recent population data suggesting PKD1 is a very low rate in Persians and other breeds.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in the discussion section.
This study found that the rate of PKD1 gene mutation was high in Persian and Persian-related breed cats including Scottish Folds cats, Previous reports has been suggested that PKD1 mutation was found at very low rates in Persians and other breeds which is contrary to our results. The high number of PKD1 mutations that had been reported may be due to the Persian and Persian-related breed cats being a popular cat breed in eastern countries and Thailand.

BUN is high for both populations – age correlation is important – please comment.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results and discussion part.
As indicated in Table 2, the levels of BUN were mildly elevated than the normal reference value. However, Pearson’s correlation results revealed that there was no correlation between age and BUN levels in WT (r=0.1436 P = 0.62) and PKD1 mutation group (r=0.3234 P = 0.099).

PKD is one of the most common hereditary diseases – actually simple Mendelian diseases in cats. HCM may be more common but has a complex inheritance.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
Feline polycystic kidney disease (PKD) is an inherited disorder that develops cysts in the renal parenchyma.

Was the hair clipped for the US evaluations or alcohol or gel applied for US?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the materials and methods part.
In our ultrasonographic examination, all cats were clipped the hair in the abdominal area and the ultrasonographic gel was used in all cats.

Overall creatinine for overall population was 2.21 _ 0.19 – odd not intermediate – correct?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
Additionally, the results of average creatinine levels in overall cats were elevated. Nonetheless, our results demonstrated that increasing creatinine exceeding 2.0 mg% may slightly increase the possibility for renal cyst formation by 1.41 times (95% CI, 0.3827 to 5.1764, P = 0.6070).

Which was most predictive of PKD – renal failure, number of cysts, age, BUN, SDMA? Any cats in renal failure?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part. The enrolled cats in this study are represented with either renal failure or non-renal failure.
Therefore, cats with increasing SDMA, an age exceeding 36 months, body weight between 2-4 kg, and renal cyst formation from ultrasonographic examination are a high possibility of PKD1 gene mutation with PKD disorder.
According to the elevated BUN in our study, the enrolled cats in this study are represented with either renal failure or non-renal failure. The high levels of BUN and increasing age were not related in contrast with the prior study from humans at that age and BUN indicated a positive correlation.

Was left to right kidney size significantly different in PKD1 cats?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
However, there was no statistically significant difference between right and left kidney size in cats affected with PKD1 mutation (P=0.9980).

Figure 4 would be better with biochemistries and cysts, kidney size, in affected cats versus normal. More figures like this, less pie charts.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript and added Figure 4.

The results showed that age and weight were negatively related to the number of cysts? I think this is misstated in results.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion part. As in Figure 4, the results of matrix correlation show a negative correlation between the number of cysts and body weight (r=0.08) and age (r=0.44).
Nevertheless, our study indicated a negative correlation between the age and the number of cysts in recruited cats. Moreover, the cats in this study have a negative correlation between cyst number and body weight. This could potentially result from the manifestation of PKD symptoms in cats with PKD1 mutation.

"The feline Polycystin-1 (PKD1) gene was examined for the point of 85% of causal mutations" – not sure what this means.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
The polycystin-1 (PKD1) gene mutation was indicated for 85% of human autosomal dominant polycystic kidney disease (ADPKD). The mutation of the PKD1 gene in cats carried heterozygous CA transversion at c.10063 in exon 29, resulting in impaired renal function.

Best regards
Soontaree Petchdee
Corresponding author
Competing Interests: No competing interests were disclosed. Close
Report a concern
Respond or Comment

COMMENTS ON THIS REPORT

Author Response 30 Nov 2023

Soontaree Petchdee, Department of Large Animal and Wildlife Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand

30 Nov 2023

Author Response

Reviewer1:
The authors present a dataset including 108 cats in which 21 had the variant for PKD1. The dataset is important however the authors need to do some different presentations ... Continue reading Reviewer1:
The authors present a dataset including 108 cats in which 21 had the variant for PKD1. The dataset is important however the authors need to do some different presentations that would be of more significant value to the veterinary and PKD research communities. Hence. “partly” for the interpretation of data. Partly for data presentation as all US images are not available.
The authors should note 87 cats had no cysts at all. What is the frequency of singular cysts in humans, I think this supports cats rarely have singular cysts, or at least less commonly than humans.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion section.
Of the total 108 cats examined by ultrasound, no cyst was found in 87 cats of the wild-type group. However,19 cats were confirmed to have renal cysts, and in every cat with cysts found, a PKD1 mutation was presented.

18 Persian cats, 49 Persian-related breed cats, 22 domestic shorthair cats, and 19 Bengal cats – need a table with age at US for each cat – the figures are less useful. Produce a summary table that summarizes groups, per breed, the cats without the PKD1 variant and then provide each breed cat that had PKD individually.
Which cat had PKD1 variant but no cysts – what was the cat’s age? Mention this in the text.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in Table 3 and mentioned more information in the results part. We apologize for this point.
However, there was a 51-month-old domestic shorthair cat without the PKD1 gene mutation developing the cysts in renal parenchyma. Table 3 demonstrates the number of cats in various breeds with PKD1 gene mutation and renal cyst development.

Scottish Folds are popular in eastern countries, however, the rate of PKD is high – contrast to other, recent population data suggesting PKD1 is a very low rate in Persians and other breeds.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in the discussion section.
This study found that the rate of PKD1 gene mutation was high in Persian and Persian-related breed cats including Scottish Folds cats, Previous reports has been suggested that PKD1 mutation was found at very low rates in Persians and other breeds which is contrary to our results. The high number of PKD1 mutations that had been reported may be due to the Persian and Persian-related breed cats being a popular cat breed in eastern countries and Thailand.

BUN is high for both populations – age correlation is important – please comment.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results and discussion part.
As indicated in Table 2, the levels of BUN were mildly elevated than the normal reference value. However, Pearson’s correlation results revealed that there was no correlation between age and BUN levels in WT (r=0.1436 P = 0.62) and PKD1 mutation group (r=0.3234 P = 0.099).

PKD is one of the most common hereditary diseases – actually simple Mendelian diseases in cats. HCM may be more common but has a complex inheritance.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
Feline polycystic kidney disease (PKD) is an inherited disorder that develops cysts in the renal parenchyma.

Was the hair clipped for the US evaluations or alcohol or gel applied for US?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the materials and methods part.
In our ultrasonographic examination, all cats were clipped the hair in the abdominal area and the ultrasonographic gel was used in all cats.

Overall creatinine for overall population was 2.21 _ 0.19 – odd not intermediate – correct?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
Additionally, the results of average creatinine levels in overall cats were elevated. Nonetheless, our results demonstrated that increasing creatinine exceeding 2.0 mg% may slightly increase the possibility for renal cyst formation by 1.41 times (95% CI, 0.3827 to 5.1764, P = 0.6070).

Which was most predictive of PKD – renal failure, number of cysts, age, BUN, SDMA? Any cats in renal failure?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part. The enrolled cats in this study are represented with either renal failure or non-renal failure.
Therefore, cats with increasing SDMA, an age exceeding 36 months, body weight between 2-4 kg, and renal cyst formation from ultrasonographic examination are a high possibility of PKD1 gene mutation with PKD disorder.
According to the elevated BUN in our study, the enrolled cats in this study are represented with either renal failure or non-renal failure. The high levels of BUN and increasing age were not related in contrast with the prior study from humans at that age and BUN indicated a positive correlation.

Was left to right kidney size significantly different in PKD1 cats?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
However, there was no statistically significant difference between right and left kidney size in cats affected with PKD1 mutation (P=0.9980).

Figure 4 would be better with biochemistries and cysts, kidney size, in affected cats versus normal. More figures like this, less pie charts.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript and added Figure 4.

The results showed that age and weight were negatively related to the number of cysts? I think this is misstated in results.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion part. As in Figure 4, the results of matrix correlation show a negative correlation between the number of cysts and body weight (r=0.08) and age (r=0.44).
Nevertheless, our study indicated a negative correlation between the age and the number of cysts in recruited cats. Moreover, the cats in this study have a negative correlation between cyst number and body weight. This could potentially result from the manifestation of PKD symptoms in cats with PKD1 mutation.

"The feline Polycystin-1 (PKD1) gene was examined for the point of 85% of causal mutations" – not sure what this means.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
The polycystin-1 (PKD1) gene mutation was indicated for 85% of human autosomal dominant polycystic kidney disease (ADPKD). The mutation of the PKD1 gene in cats carried heterozygous CA transversion at c.10063 in exon 29, resulting in impaired renal function.

Best regards
Soontaree Petchdee
Corresponding author
Reviewer1:
The authors present a dataset including 108 cats in which 21 had the variant for PKD1. The dataset is important however the authors need to do some different presentations that would be of more significant value to the veterinary and PKD research communities. Hence. “partly” for the interpretation of data. Partly for data presentation as all US images are not available.
The authors should note 87 cats had no cysts at all. What is the frequency of singular cysts in humans, I think this supports cats rarely have singular cysts, or at least less commonly than humans.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion section.
Of the total 108 cats examined by ultrasound, no cyst was found in 87 cats of the wild-type group. However,19 cats were confirmed to have renal cysts, and in every cat with cysts found, a PKD1 mutation was presented.

18 Persian cats, 49 Persian-related breed cats, 22 domestic shorthair cats, and 19 Bengal cats – need a table with age at US for each cat – the figures are less useful. Produce a summary table that summarizes groups, per breed, the cats without the PKD1 variant and then provide each breed cat that had PKD individually.
Which cat had PKD1 variant but no cysts – what was the cat’s age? Mention this in the text.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in Table 3 and mentioned more information in the results part. We apologize for this point.
However, there was a 51-month-old domestic shorthair cat without the PKD1 gene mutation developing the cysts in renal parenchyma. Table 3 demonstrates the number of cats in various breeds with PKD1 gene mutation and renal cyst development.

Scottish Folds are popular in eastern countries, however, the rate of PKD is high – contrast to other, recent population data suggesting PKD1 is a very low rate in Persians and other breeds.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in the discussion section.
This study found that the rate of PKD1 gene mutation was high in Persian and Persian-related breed cats including Scottish Folds cats, Previous reports has been suggested that PKD1 mutation was found at very low rates in Persians and other breeds which is contrary to our results. The high number of PKD1 mutations that had been reported may be due to the Persian and Persian-related breed cats being a popular cat breed in eastern countries and Thailand.

BUN is high for both populations – age correlation is important – please comment.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results and discussion part.
As indicated in Table 2, the levels of BUN were mildly elevated than the normal reference value. However, Pearson’s correlation results revealed that there was no correlation between age and BUN levels in WT (r=0.1436 P = 0.62) and PKD1 mutation group (r=0.3234 P = 0.099).

PKD is one of the most common hereditary diseases – actually simple Mendelian diseases in cats. HCM may be more common but has a complex inheritance.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
Feline polycystic kidney disease (PKD) is an inherited disorder that develops cysts in the renal parenchyma.

Was the hair clipped for the US evaluations or alcohol or gel applied for US?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the materials and methods part.
In our ultrasonographic examination, all cats were clipped the hair in the abdominal area and the ultrasonographic gel was used in all cats.

Overall creatinine for overall population was 2.21 _ 0.19 – odd not intermediate – correct?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
Additionally, the results of average creatinine levels in overall cats were elevated. Nonetheless, our results demonstrated that increasing creatinine exceeding 2.0 mg% may slightly increase the possibility for renal cyst formation by 1.41 times (95% CI, 0.3827 to 5.1764, P = 0.6070).

Which was most predictive of PKD – renal failure, number of cysts, age, BUN, SDMA? Any cats in renal failure?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part. The enrolled cats in this study are represented with either renal failure or non-renal failure.
Therefore, cats with increasing SDMA, an age exceeding 36 months, body weight between 2-4 kg, and renal cyst formation from ultrasonographic examination are a high possibility of PKD1 gene mutation with PKD disorder.
According to the elevated BUN in our study, the enrolled cats in this study are represented with either renal failure or non-renal failure. The high levels of BUN and increasing age were not related in contrast with the prior study from humans at that age and BUN indicated a positive correlation.

Was left to right kidney size significantly different in PKD1 cats?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
However, there was no statistically significant difference between right and left kidney size in cats affected with PKD1 mutation (P=0.9980).

Figure 4 would be better with biochemistries and cysts, kidney size, in affected cats versus normal. More figures like this, less pie charts.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript and added Figure 4.

The results showed that age and weight were negatively related to the number of cysts? I think this is misstated in results.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion part. As in Figure 4, the results of matrix correlation show a negative correlation between the number of cysts and body weight (r=0.08) and age (r=0.44).
Nevertheless, our study indicated a negative correlation between the age and the number of cysts in recruited cats. Moreover, the cats in this study have a negative correlation between cyst number and body weight. This could potentially result from the manifestation of PKD symptoms in cats with PKD1 mutation.

"The feline Polycystin-1 (PKD1) gene was examined for the point of 85% of causal mutations" – not sure what this means.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
The polycystin-1 (PKD1) gene mutation was indicated for 85% of human autosomal dominant polycystic kidney disease (ADPKD). The mutation of the PKD1 gene in cats carried heterozygous CA transversion at c.10063 in exon 29, resulting in impaired renal function.

Best regards
Soontaree Petchdee
Corresponding author
Competing Interests: No competing interests were disclosed. Close
Report a concern

Comments on this article Comments (0)

Version 3

VERSION 3 PUBLISHED 28 Jun 2023

Open Peer Review

Reviewer Status

Reviewer Reports

	Invited Reviewers
	1	2	3
Version 3 (revision) 23 Feb 24			read
Version 2 (revision) 27 Oct 23	read	read
Version 1 28 Jun 23	read

Leslie A. Lyons, University of Missouri, Columbia, USA
Stephen C Parnell, University of Kansas Medical Center, Kansas, USA
Jin He, Zhejiang University, Hangzhou, China; Zhejiang University, Hangzhou, China

Comments on this article

All Comments(0)

Add a comment

Browse by related subjects

Back to all reports

Reviewer Report

10 Views

05 Aug 2024 | for Version 3

Jin He, Zhejiang University, Hangzhou, Zhejiang, China; College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, China

10 Views Cite this report Responses(0)

Approved With Reservations

The manuscript by Jaturanratsamee et al. presents a comprehensive study investigating the correlation between polycystic kidney disease (PKD) and the PKD1 gene mutation in cats. Utilizing a cohort of 108 cats across various breeds, the authors employ a multimodal approach, including blood examination, biochemical tests, renal ultrasound, and genetic analysis via polymerase chain reaction (PCR) and DNA sequencing. The primary objective is to assess the prevalence of PKD1 gene mutations and to characterize the associated renal phenotypes using ultrasonography, with the ultimate goal of informing treatment strategies and prevalence estimates for feline PKD.

The study's design is robust, incorporating a broad sample of cat breeds and a systematic methodology for data collection and analysis. The use of both imaging and genetic techniques provides a dual perspective on the disease's presentation, offering valuable insights into the phenotypic expression of the PKD1 mutation in cats. The manuscript also discusses the implications of these findings for clinical practice, emphasizing the potential of ultrasonography as a diagnostic tool for identifying PKD1 gene carriers.

However, as with any research, there are aspects of the study that warrant further consideration and clarification. The following comments will address specific areas where additional information, refinement, or alternative approaches may enhance the study's validity, reproducibility, and overall contribution to the field of veterinary genetics and nephrology.

1) Similar to Reviewer 1, I am curious about the selection of cats involved in the study. Are they typically normal-conditioned cats or sick ones? If they belong to the latter category, then the calculated ratios might be overestimated.
2) The authors stated in the statistics section that paired t-tests were utilized in the study. However, I am unsure how a paired test could be applied to analyze Table 1. As a biologist with extensive experience in statistics teaching, I would argue that only the comparison between the left kidney size and the right kidney size could be analyzed using this method. Besides, normalization of kidney size with their respective body weights may be a better way of presenting the data.
3) The authors mentioned the use of multiple linear models; however, I was unable to locate them in the manuscript.
4) In Table 2, I am puzzled by how the overall creatinine level can be calculated as 2.21 when the constituent parts of the population are recorded as 1.95 and 2.00.
5) The authors should include a discussion on SDMA in comparison to creatinine, which could benefit biologists with limited clinical backgrounds, since creatinine levels are commonly utilized in research.
6) I am curious about the calculation of the odds ratio given that there are no false-negative cases. Additionally, the specificity presented differs from my own calculations.
7) The PCR genotyping method may only cover a portion of the feline PKD1 gene, implying that the 'wild-type' (WT) cats might also harbor PKD1 mutations. This concern was raised by other reviewers, but it seems to me that the authors have not adequately addressed it.
8) Is there a gold standard or diagnostic criterion in veterinary medicine for ADPKD, similar to the Ravine criterion used in human studies? Cyst formation could also be a result of other diseases.
9) Considering the above comments, the authors should carefully select appropriate terminology to describe and discuss their findings. Their conclusions may only be valid within the context of the specific population studied, potential undetected PKD1 mutations, and the diagnostic methods employed.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Partly
Are sufficient details of methods and analysis provided to allow replication by others?

Partly
If applicable, is the statistical analysis and its interpretation appropriate?

No
Are all the source data underlying the results available to ensure full reproducibility?

Partly
Are the conclusions drawn adequately supported by the results?

Yes

References

1. Jaturanratsamee K, Choisunirachon N, Soontornvipart K, Darawiroj D, et al.: Ultrasonographic kidney length-to-abdominal aortic diameter for the diagnosis of feline chronic kidney disease: A preliminary study.Vet World. 2023; 16 (5): 1114-1121 PubMed Abstract | Publisher Full Text

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Animal models of ADPKD. Statistical genetics and genomics.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

15 Views

05 Feb 2024 | for Version 2

Stephen C Parnell, University of Kansas Medical Center, Kansas, USA

15 Views Cite this report Responses(1)

Approved With Reservations

In the manuscript “PKD1 gene mutation and ultrasonographic characterization in cats with renal cyst” authors Jaturanratsamee and others use ultrasonography to investigate the association between clinical presentation of polycystic kidney disease (PKD) in a population of non-experimental house cats including animals with or without feline PKD1 gene mutation. The stated purpose of the study is to guide treatment options and to help estimate the prevalence of PKD in cats.

Animals enrolled in the study were examined by routine medical exam, ultrasonography, serum biochemistry, and targeted PCR analysis of the feline PKD1 gene. Relationships between genotype and phenotype are presented.

The stated conclusions for the study are that the frequency of PKD1 mutations are high in Persian and Persian-related breeds, that PKD1 mutation correlates with the PKD phenotype, and that ultrasonography can be a helpful tool to identify carriers of the mutated feline PKD1 gene.
The study is well-conducted for the most part, but I have a few questions and minor corrections that the authors should address.

The items listed below should be addressed in a revised version.

This portion of the manuscript is not clear to me: Of the total 108 cats examined by ultrasound, no cyst was found in 87 cats of the wild-type group. However, 19 cats were confirmed to have renal cysts, and in every cat with cysts found, a PKD1 mutation was present.
An older domestic shorthair with cysts but no evidence of the relevant PKD1 mutation was reported elsewhere in the manuscript and should be addressed again at this point.
Is it possible that the 51-month specimen represents a novel PKD1 mutation? Were the cysts in this animal unilateral or bilateral?
Have additional PKD1 mutations been identified within cats, or is the c.10063 CA transversion the only mutation identified to date? If so then this is interesting given the very large number of unique PKD1 mutations in the ADPKD patient population, but raises a more fundamental question. The authors conclude that “ultrasonographic examination of cats will be a helpful tool for the routine identification of carriers of the mutated gene for polycystic kidney disease in cats.” The manuscript reports sensitivity of only 75% at 16 week of age - isn’t this close to sexual maturity? If there is a single founder mutation for PKD in cats then wouldn’t a PCR-based assay (which could be performed well before sexual maturity) be much more useful for diagnosis than ultransonography? The authors should discuss this, and also note the age of sexual maturity in cats.
The cats with mutant PKD1 are on average almost 17-months older than the wild-type cats. This seems non-random. How were study animals selected, and has there been any consideration of whether there could be selection biases that affect interpretation of the data?

The items listed below should be corrected or amended in the final version.

In Figure 3 B/C are both labelled as Right Kidney. One should be the data for the left kidney.
In Figure 4 the chemical name is listed as “alanine” but it should be “adenine”. Please indicate the resulting protein mutation caused by this transversion.
In Table 2 please indicate the percentage of cystic cats in which the cysts are unilateral vs bilateral.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Partly

Competing Interests

No competing interests were disclosed.

Respond to this report

Responses (1)

Author Response

13 Apr 2024

Soontaree Petchdee, Department of Large Animal and Wildlife Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand

We have provided a point-by-point reply to each point raised by the reviewers as a separate file and indicated any changes or corrections within the text in blue on the resubmitted manuscript. Please see below for the list of changes.
Comments to the Author;
Reviewer 2:
This portion of the manuscript is not clear to me: Of the total 108 cats examined by ultrasound, no cyst was found in 87 cats of the wild-type group. However, 19 cats were confirmed to have renal cysts, and in every cat with cysts found, a PKD1 mutation was present. An older domestic shorthair with cysts but no evidence of the relevant PKD1 mutation was reported elsewhere in the manuscript and should be addressed again at this point. Is it possible that the 51-month specimen represents a novel PKD1 mutation? Were the cysts in this animal unilateral or bilateral?
Answer to the reviewer: We apologize for the unclear on this point. We have edited this point in the revised manuscript in the discussion section.
The 51-month-old cat may represent a PKD1 mutation, and it usually correlates with a bilateral cyst. The cysts detected are sufficient for a positive diagnosis in young cats up to 12 months of age. In addition, these criteria will help to determine a positive result for PKD1 mutations if multiple bilateral cysts are detected (>10 per kidney) or if cysts are not detected in older cats. The results from this study are similar to a previous study that reported a positive correlation between the detection of renal cysts and age, as cyst detection was increased in older animals.
Have additional PKD1 mutations been identified within cats, or is the c.10063 CA transversion the only mutation identified to date? If so then this is interesting given the very large number of unique PKD1 mutations in the ADPKD patient population, but raises a more fundamental question. The authors conclude that “ultrasonographic examination of cats will be a helpful tool for the routine identification of carriers of the mutated gene for polycystic kidney disease in cats.” The manuscript reports a sensitivity of only 75% at 16 weeks of age - isn’t this close to sexual maturity? If there is a single founder mutation for PKD in cats then wouldn’t a PCR-based assay (which could be performed well before sexual maturity) be much more useful for diagnosis than ultrasonography? The authors should discuss this and also note the age of sexual maturity in cats.
Answer to the reviewer: We apologize for the unclear on this point. We have edited this point in the revised manuscript in the discussion and conclusion section.
Similar to our study, in the previous study, ultrasound provided more sensitivity when diagnosing cats of maturity age, which had a sensitivity of 91% when performed at 36 weeks of age. In our study, we suggested that ultrasonographic examination of cats will be a helpful tool for the routine identification of carriers of the mutated gene for polycystic kidney disease in mature cats.
A previous study reported sexual maturation in the domestic cat based on histological examination of seminiferous tubules, cats were classified as juvenile (<9 months; only spermatogonia and Sertoli cells present), pubertal (≥9 months to <1 year; complete spermatogenesis), and adult (>2 years; spermiogenesis complete and cauda epididymis filled with spermatozoa).
(Ref.) Schön, J., Neumann, S., Wildt, D. E., Pukazhenthi, B. S., & Jewgenow, K. (2009). Localization of oestrogen receptors in the epididymis during sexual maturation of the domestic cat. Reproduction in domestic animals = Zuchthygiene, 44 Suppl 2, 294–301. https://doi.org/10.1111/j.1439-0531.2009.01391.x
The cats with mutant PKD1 are on average almost 17 months older than the wild-type cats. This seems non-random. How were study animals selected, and has there been any consideration of whether there could be selection biases that affect the interpretation of the data?
Answer to the reviewer: We appreciate the helpful comment and apologize for the unclear on this point. The animals in this present study were truly randomized. We were random and blind in all the processes. The person who performed the ultrasounds, the person who recorded the genetic parameters, and the person who analyzed the data were different persons.
In Figure 3 B/C are both labelled as Right Kidney. One should be the data for the left kidney.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript
In Figure 4 the chemical name is listed as “alanine” but it should be “adenine”. Please indicate the resulting protein mutation caused by this transversion.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript
In Table 2 please indicate the percentage of cystic cats in which the cysts are unilateral vs bilateral.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript
Best regards
Soontaree Petchdee
Corresponding author

View more View less

Competing Interests

No competing interests were disclosed.

Back to all reports

Reviewer Report

6 Views

03 Nov 2023 | for Version 2

Leslie A. Lyons, Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO, USA

6 Views Cite this report Responses(0)

Approved

Authors have made appropriate corrections.

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Genetics PKD feline diseases

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

19 Views

16 Oct 2023 | for Version 1

Leslie A. Lyons, Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO, USA

19 Views Cite this report Responses(1)

Not Approved

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Partly
Are the conclusions drawn adequately supported by the results?

Partly

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Genetics PKD feline diseases

Respond to this report

Responses (1)

Author Response

30 Nov 2023

Soontaree Petchdee, Department of Large Animal and Wildlife Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand

Reviewer1:
The authors present a dataset including 108 cats in which 21 had the variant for PKD1. The dataset is important however the authors need to do some different presentations that would be of more significant value to the veterinary and PKD research communities. Hence. “partly” for the interpretation of data. Partly for data presentation as all US images are not available.
The authors should note 87 cats had no cysts at all. What is the frequency of singular cysts in humans, I think this supports cats rarely have singular cysts, or at least less commonly than humans.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion section.
Of the total 108 cats examined by ultrasound, no cyst was found in 87 cats of the wild-type group. However,19 cats were confirmed to have renal cysts, and in every cat with cysts found, a PKD1 mutation was presented.

18 Persian cats, 49 Persian-related breed cats, 22 domestic shorthair cats, and 19 Bengal cats – need a table with age at US for each cat – the figures are less useful. Produce a summary table that summarizes groups, per breed, the cats without the PKD1 variant and then provide each breed cat that had PKD individually.
Which cat had PKD1 variant but no cysts – what was the cat’s age? Mention this in the text.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in Table 3 and mentioned more information in the results part. We apologize for this point.
However, there was a 51-month-old domestic shorthair cat without the PKD1 gene mutation developing the cysts in renal parenchyma. Table 3 demonstrates the number of cats in various breeds with PKD1 gene mutation and renal cyst development.

Scottish Folds are popular in eastern countries, however, the rate of PKD is high – contrast to other, recent population data suggesting PKD1 is a very low rate in Persians and other breeds.
Answer to the reviewer: We appreciate the helpful comment. We have edited this point in the revised manuscript in the discussion section.
This study found that the rate of PKD1 gene mutation was high in Persian and Persian-related breed cats including Scottish Folds cats, Previous reports has been suggested that PKD1 mutation was found at very low rates in Persians and other breeds which is contrary to our results. The high number of PKD1 mutations that had been reported may be due to the Persian and Persian-related breed cats being a popular cat breed in eastern countries and Thailand.

BUN is high for both populations – age correlation is important – please comment.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results and discussion part.
As indicated in Table 2, the levels of BUN were mildly elevated than the normal reference value. However, Pearson’s correlation results revealed that there was no correlation between age and BUN levels in WT (r=0.1436 P = 0.62) and PKD1 mutation group (r=0.3234 P = 0.099).

PKD is one of the most common hereditary diseases – actually simple Mendelian diseases in cats. HCM may be more common but has a complex inheritance.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
Feline polycystic kidney disease (PKD) is an inherited disorder that develops cysts in the renal parenchyma.

Was the hair clipped for the US evaluations or alcohol or gel applied for US?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the materials and methods part.
In our ultrasonographic examination, all cats were clipped the hair in the abdominal area and the ultrasonographic gel was used in all cats.

Overall creatinine for overall population was 2.21 _ 0.19 – odd not intermediate – correct?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
Additionally, the results of average creatinine levels in overall cats were elevated. Nonetheless, our results demonstrated that increasing creatinine exceeding 2.0 mg% may slightly increase the possibility for renal cyst formation by 1.41 times (95% CI, 0.3827 to 5.1764, P = 0.6070).

Which was most predictive of PKD – renal failure, number of cysts, age, BUN, SDMA? Any cats in renal failure?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part. The enrolled cats in this study are represented with either renal failure or non-renal failure.
Therefore, cats with increasing SDMA, an age exceeding 36 months, body weight between 2-4 kg, and renal cyst formation from ultrasonographic examination are a high possibility of PKD1 gene mutation with PKD disorder.
According to the elevated BUN in our study, the enrolled cats in this study are represented with either renal failure or non-renal failure. The high levels of BUN and increasing age were not related in contrast with the prior study from humans at that age and BUN indicated a positive correlation.

Was left to right kidney size significantly different in PKD1 cats?
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the results part.
However, there was no statistically significant difference between right and left kidney size in cats affected with PKD1 mutation (P=0.9980).

Figure 4 would be better with biochemistries and cysts, kidney size, in affected cats versus normal. More figures like this, less pie charts.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript and added Figure 4.

The results showed that age and weight were negatively related to the number of cysts? I think this is misstated in results.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the discussion part. As in Figure 4, the results of matrix correlation show a negative correlation between the number of cysts and body weight (r=0.08) and age (r=0.44).
Nevertheless, our study indicated a negative correlation between the age and the number of cysts in recruited cats. Moreover, the cats in this study have a negative correlation between cyst number and body weight. This could potentially result from the manifestation of PKD symptoms in cats with PKD1 mutation.

"The feline Polycystin-1 (PKD1) gene was examined for the point of 85% of causal mutations" – not sure what this means.
Answer to the reviewer: We apologize for this point. We have edited this point in the revised manuscript in the introduction part.
The polycystin-1 (PKD1) gene mutation was indicated for 85% of human autosomal dominant polycystic kidney disease (ADPKD). The mutation of the PKD1 gene in cats carried heterozygous CA transversion at c.10063 in exon 29, resulting in impaired renal function.

Best regards
Soontaree Petchdee
Corresponding author

View more View less

Competing Interests

No competing interests were disclosed.

Alongside their report, reviewers assign a status to the article:

Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions

[1] 1. Lyons LA, Biller DS, Erdman CA, et al.: Feline polycystic kidney disease mutation identified in PKD1. J. Am. Soc. Nephrol. 2004; 15: 2548–2555. PubMed Abstract | Publisher Full Text

[2] 2. Eaton KA, Biller DS, DiBartola SP, et al.: Autosomal dominant polycystic kidney disease in Persian and Persian-cross cats. Vet. Pathol. 1997; 34: 117–126. PubMed Abstract | Publisher Full Text

[3] 3. Schirrer L, Marín-García PJ, Llobat L: Feline polycystic kidney disease: an update. Vet. Sci. 2021; 8: 269. PubMed Abstract | Publisher Full Text | Free Full Text

[4] 4. Beck C, Lavelle RB: Feline polycystic kidney disease in Persian and other cats: a prospective study using ultrasonography. Aust. Vet. J. 2001; 79: 181–184. PubMed Abstract | Publisher Full Text

[5] 5. Barrs VR, Gunew M, Foster SF, et al.: Prevalence of autosomal dominant polycystic kidney disease in Persian cats and related-breeds in Sydney and Brisbane. Aust. Vet. J. 2001; 79: 257–259. PubMed Abstract | Publisher Full Text

[6] 6. Barthez PY, Rivier P, Begon D: Prevalence of polycystic kidney disease in Persian and Persian related cats in France. J. Feline Med. Surg. 2003; 5: 345–347. PubMed Abstract | Publisher Full Text

[7] 7. Grahn R, Biller D, Young AE, et al.: Genetic testing for feline polycystic kidney disease. Anim. Genet. 2004; 35: 503–504. PubMed Abstract | Publisher Full Text

[8] 8. Nivy R, Lyons L, Aroch I, et al.: Polycystic kidney disease in four British shorthair cats with successful treatment of bacterial cyst infection. J. Small Anim. Pract. 2015; 56: 585–589. PubMed Abstract | Publisher Full Text

[9] 9. Cornec-Le Gall E, Torres VE, Harris PC: Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J. Am. Soc. Nephrol. 2018; 29: 13–23. PubMed Abstract | Publisher Full Text | Free Full Text

[10] 10. Torres VE, Chapman AB, Devuyst O, et al.: Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 2012; 367: 2407–2418. PubMed Abstract | Publisher Full Text | Free Full Text

[11] 11. Rinschen MM, Schermer B, Benzing T: Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again. J. Am. Soc. Nephrol. 2014; 25: 1140–1147. PubMed Abstract | Publisher Full Text

[12] 12. Torres VE, Chapman AB, Devuyst O, et al.: Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N. Engl. J. Med. 2017; 377: 1930–1942. PubMed Abstract | Publisher Full Text

[13] 13. Rowe I, Chiaravalli M, Mannella V, et al.: Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 2013; 19: 488–493. PubMed Abstract | Publisher Full Text | Free Full Text

[14] 14. Kobayashi S, Kawarasaki M, Aono A, et al.: Renoprotective effects of docosahexaenoic acid in cats with early chronic kidney disease due to polycystic kidney disease: a pilot study. J. Feline Med. Surg. 2022; 24: e505–e512. PubMed Abstract | Publisher Full Text

[15] 15. Domanjko-Petrič A, Černec D, Cotman M: Polycystic kidney disease: a review and occurrence in Slovenia with comparison between ultrasound and genetic testing. J. Feline Med. Surg. 2008; 10: 115–119. PubMed Abstract | Publisher Full Text

[16] 16. Wills SJ, Barrett EL, Barr FJ, et al.: Evaluation of the repeatability of ultrasound scanning for detection of feline polycystic kidney disease. J. Feline Med. Surg. 2009; 11: 993–996. PubMed Abstract | Publisher Full Text

[17] 17. Bartges JW: Chronic kidney disease in dogs and cats. Vet. Clin. Small Anim. Pract. 2012; 42: 669–692. Publisher Full Text

[18] 18. Lee YJ, Chen HY, Hsu WL, et al.: Diagnosis of feline polycystic kidney disease by combining ultrasonographic examination and PKD1 gene analysis. Vet. Rec. 2010; 167: 614–618. PubMed Abstract | Publisher Full Text

[19] 19. Biller DS, DiBartola S, Eaton KA, et al.: Inheritance of polycystic kidney disease in Persian cats. J. Hered. 1996; 87: 1–5. Publisher Full Text

[20] 20. Bonazzi M, Volta A, Gnudi G, et al.: Comparison between ultrasound and genetic testing for the early diagnosis of polycystic kidney disease in Persian and Exotic Shorthair cats. J. Feline Med. Surg. 2009; 11: 430–434. Publisher Full Text

[21] 21. Gendron K, Owczarek-Lipska M, Lang J, et al.: Maine Coon renal screening: ultrasonographical characterization and preliminary genetic analysis for common genes in cats with renal cysts. J. Feline Med. Surg. 2013; 15: 1079–1085. PubMed Abstract | Publisher Full Text

[22] 22. Noori Z, Moosavian HR, Esmaeilzadeh H, et al.: Prevalence of polycystic kidney disease in Persian and Persian related-cats referred to Small Animal Hospital, University of Tehran, Iran. Iranian J. Vet. Res. 2019; 20: 151.

[23] 23. Ecder T, Melnikov VY, Stanley M, et al.: Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int. 2002; 61: 1220–1230. PubMed Abstract | Publisher Full Text

[24] 24. Zeng F, Miyazawa T, Kloepfer LA, et al.: Deletion of ErbB4 accelerates polycystic kidney disease progression in cpk mice. Kidney Int. 2014; 86: 538–547.

[25] 25. Nowak KL, Edelstein CL: Apoptosis and autophagy in polycystic kidney disease (PKD). Cell. Signal. 2020; 68: 109518. Publisher Full Text

[26] 26. Richards T, Modarage K, Malik SA, et al.: The cellular pathways and potential therapeutics of Polycystic Kidney Disease. Biochem. Soc. Trans. 2021; 49: 1171–1188. Publisher Full Text

[27] 27. Bilgen N, Bişkin Türkmen MB, Çınar Kul B, et al.: Prevalence of PKD1 gene mutation in cats in Turkey and pathogenesis of feline polycystic kidney disease. J. Vet. Diagn. Investig. 2020; 32: 549–555. PubMed Abstract | Publisher Full Text | Free Full Text

[28] 28. Xue C, Mei C-L: Polycystic kidney disease and renal fibrosis. Renal fibrosis: mechanisms and therapies.2019; pp. 81–100.

[29] 29. Swenson-Fields KI, Ward CJ, Lopez ME, et al.: Caspase-1 and the inflammasome promote polycystic kidney disease progression. Front. Mol. Biosci. 2022; 9: 1300. Publisher Full Text

[30] 30. Tao Y, Kim J, Faubel S, et al.: Caspase inhibition reduces tubular apoptosis and proliferation, slowing disease progression in polycystic kidney disease. Proc. Natl. Acad. Sci. 2005; 102: 6954–6959.

[31] 31. Patel V, Chowdhury R, Igarashi P: Advances in the pathogenesis and treatment of polycystic kidney disease. Curr. Opin. Nephrol. Hypertens. 2009; 18: 99–106. PubMed Abstract | Publisher Full Text | Free Full Text

[32] 32. Blair HA: Tolvaptan: a review in autosomal dominant polycystic kidney disease. Drugs. 2019; 79: 303–313. Publisher Full Text

[33] 33. Bellos I: Safety profile of Tolvaptan in the treatment of autosomal dominant polycystic kidney disease. Ther. Clin. Risk Manag. 2021; 649–656.

[34] 34. Lian X, Wu X, Li Z, et al.: The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease. Br. J. Pharmacol. 2019; 176: 711–724. PubMed Abstract | Publisher Full Text | Free Full Text

[35] 35. Gattone VH, Wang X, Harris PC, et al.: Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 2003; 9: 1323–1326. PubMed Abstract | Publisher Full Text

[36] 36. Petchdee S: Raw data PKD1 in cats. [Dataset]. figshare. 2023. Publisher Full Text

[37] 37. Petchdee S: Figures. [Dataset]. figshare. 2023. Publisher Full Text

[38] 38. Petchdee S: consent form. [Dataset]. figshare. 2023. Publisher Full Text

[39] 39. Petchdee S: ARRIVE checklist_edited. [Dataset]. figshare. 2023. Publisher Full Text

PKD1 gene mutation and ultrasonographic characterization in cats with renal cysts

Abstract

Keywords

Introduction

Methods

Animals

Figure 1. Overall population in this study.

Figure 2. Ultrasound image of kidneys with cysts.

Polymerase chain reaction and DNA sequencing

Ultrasonography

Statistical analysis

Results

Characteristics, ultrasonographic variables, and serum biochemical findings

Table 1. Characteristics and ultrasonographic variables of cats.

Table 2. Serum biochemistry, red blood cell count, and hematocrit in all cats and groups.

Sequencing results and ultrasonography correlation analysis of PKD1 in cats

Figure 3. Results of Polycystin-1 (PKD1) polymorphism from genotyping by sequencing.

Effectiveness of ultrasonography for detecting PKD1 gene mutation

Table 3. Results of the effectiveness of ultrasonography for detecting PKD1 heterozygous mutation.

Relationships between renal cysts and PKD1 genotypes in cats

Figure 4. Correlation between Polycystin-1 (PKD1), ultrasonography profiles, and clinical data (age and body weight).

Figure 5. Relationships between ages, weight, and Polycystin-1 (PKD1) gene.

Discussion

Conclusions

Ethical approval

Data availability

Underlying data

Extended data

Reporting guidelines

Acknowledgments

References

Comments on this article Comments (0)

Open Peer Review

Comments on this article Comments (0)

Open Peer Review

Reviewer Status

Reviewer Reports

Comments on this article

Browse by related subjects

Competing Interests Policy

Stay Updated